PDB30 Assessment of the Impact of the New Antidiabetic Treatment with Vildagliptin to Change the Total Costs on Diabetes Type 2
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1333
https://www.valueinhealthjournal.com/article/S1098-3015(11)02895-6/fulltext
Title :
PDB30 Assessment of the Impact of the New Antidiabetic Treatment with Vildagliptin to Change the Total Costs on Diabetes Type 2
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02895-6&doi=10.1016/j.jval.2011.08.1333
First page :
A477
Section Title :
Diabetes/Endocrine Disorders
Open access? :
No
Section Order :
1292